Skye Bioscience to Present at TD Cowen Health Care Conference
Skye is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation molecules that modulate G-protein coupled receptors. Skye's strategy leverages biologic targets with substantial human proof of mechanism for the development of first-in-class therapeutics with clinical and commercial differentiation.
Seer to Participate in the TD Cowen 45th Annual Health Care Conference
Seer’s management is scheduled to participate in a fireside chat on Tuesday, March 4 th at 11:50 a.m. Eastern Time / 8:50 a.m. Pacific Time. A live webcast of the session will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the conference.
GRAIL to Present at TD Cowen 45th Annual Health Care Conference
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the TD Cowen 45th Annual Health Care Conference in Boston on Tuesday,
Snowflake (NYSE:SNOW) was in the spotlight on Friday as TD Cowen said recent partner checks were “constructive” ahead of the ...
Oliver Chen, TD Cowen senior retail analyst, joins 'Money Movers' to discuss Wall Street's reaction to Walmart's quarterly ...
TD Cowen downgraded Parsons (PSN) to Hold from Buy with a price target of $56, down from $105. The company’s “sharp 2025 rowth deceleration and ...
Charles Schwab (NYSE:SCHW – Get Free Report) was upgraded by equities researchers at TD Cowen from a “hold” rating to a “buy” ...
TD Cowen was established in 1918 as a bond trading firm and quickly expanded into clearing and execution services. By the 1970s, it had carved a niche in railroad bonds and grown a solid research ...
TD Cowen initiated coverage of Centessa (CNTA) with a Buy rating and no price target The firm says the company’s ORX750 has a “best in class profile as a transformative therapy” in excessive ...
TriNet Group (NYSE:TNET – Get Free Report) was downgraded by equities research analysts at TD Cowen from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday, Ratings ...
Investing.com-- TD Cowen analysts said a pullback in Walmart Inc (NYSE: WMT ), on weaker-than-expected guidance, represented a buy opportunity for the stock, and that they still saw the retail giant ...
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that members of the executive team are scheduled to participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Tuesday, ...
TD Cowen lowered the firm’s price target on Freshpet (FRPT) to $141 from $174 and keeps a Buy rating on the shares post the Q4 report.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback